Unigen, Inc.
Rodney E. Storms, JD has a diverse work experience spanning various industries and roles. Rodney E. currently holds the position of Vice President, Sales & Marketing at Unigen, Inc. since August 2021. Prior to that, they served as the Regional Sales Director at the same company from June 2015 to November 2021. In 2007, Rodney served as the Chairman of Atlanta Cagers. Rodney E. also had a short-term position as the Interim President at NEXT Pharmaceuticals, Inc. in 2015. Before that, they worked as the Director of Business Development at Next Pharmaceutical, Inc. from June 2014 to January 2015. Rodney also has a considerable tenure at Unigen, Inc. where they were the National Sales Manager from June 2002 to June 2014. Rodney E. held a similar role as the National Sales Manager at ASI International from January 2000 to June 2002. Rodney began their career as the Director of Membership/Interim President at the American Herbal Products Association from January 1996 to January 2000. Prior to that, they served in the United States Air Force (USAF) as an Information Manager (702) from July 1989 to July 1996. Rodney's earliest work experience was as a Student Aide at the Ruth McClendon Office in 1995.
Overall, Rodney E. Storms, JD has gained extensive experience in sales, marketing, business development, and leadership roles throughout their career.
Rodney E. Storms, JD, obtained their Juris Doctorate degree in General Law from The Catholic University of America, Columbus School of Law, where they studied from 1999 to 2004. Prior to this, they completed their undergraduate education at The University of Texas at San Antonio, earning two Bachelor of Arts degrees in Political Science and Sociology from 1992 to 1994. Rodney E. attended Port Richmond HS from 1984 to 1988, although no specific degree or field of study was mentioned.
This person is not in any teams
This person is not in any offices
Unigen, Inc.
1 followers
From discovery to distribution, Unigen is dedicated to the development of botanical and marine-derived therapeutic compounds that address consumer health needs and improve quality of life. Established in 1996, our research and discovery process includes extensive testing at the genetic, cellular, and human clinical levels. Unigen is a global leader in the discovery and development of proprietary natural ingredients for the dietary supplement, food, cosmetics, personal care and pharmaceutical industries. With a core of scientifically substantiated natural ingredients already distribute worldwide, we continue to push the boundaries of pharmaceutical quality research and novel applications for natural products. The company has one of the most extensive medicinal plant collections in the world and utilizes a state-of-the-art pharmaceutical discovery approach to identify the most safe and effective botanically-based proprietary ingredients. The efficacy of Unigen’s natural product ingredients is established through human clinical trials, and unlike synthetic drugs, Unigen’s natural substances have a legacy of safe human consumption without the undesirable side-effects that limit the use of pharmaceuticals. Unigen protects its discoveries through patents and commercializes its products through alliances with partners that possess distribution and marketing capabilities in each of Unigen’s target markets.